Caso Clínico: CANCER DE VEJIGA Enfermedad metastásica - page 27

Tratamiento estandard

Segunda Linea

COMO ESTANDARD:

TTO MONOTERAPIA

EAU / ESMO: VINFLUNINA

NCCN: TAXANOS o GEMCITABINA

IMMUNOTERAPIA : FDA aprovado Mayo 2016

ATEZOLIZUMAB post platino

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,17,18,19,20,21,22,23,24,25,26 28,29,30,31,32,33,34,35,36,37,...44